LEONTEQ SECURITIES AG (GUERNSEY BRANCH) | Market Closed - Swiss Exchange 16:20:00 19/06/2024 BST | ||
| 95.3 CHF | -0.64% |
|
| Current month | -3.68% | ||
| 1 month | -3.50% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
| Date | Price | Change |
|---|---|---|
| 19/06/24 | 95.3 | -0.64% |
| 18/06/24 | 95.91 | -0.24% |
| 17/06/24 | 96.14 | -1.53% |
| 14/06/24 | 97.63 | -0.40% |
| 12/06/24 | 98.02 | +0.04% |
Delayed Quote Swiss Exchange
Last update June 19, 2024 at 04:20 pm
More quotesStatic data
| Product type | Reverse Convertibles |
|---|---|
| Buy / Sell | CALL |
| Underlying | MERCK & CO., INC. |
| Issuer | LEONTEQ |
| YWSLTQ | |
| ISIN | CH1314019386 |
| Date issued | 05/01/2024 |
| Strike | 117.2 $ |
| Maturity | 07/07/2025 (383 Days) |
| Parity | 1 : 1 |
| Emission price | 100 CHF |
| Emission volume | N/A |
| Settlement | both |
| Currency | CHF |
Technical Indicators
| Highest since issue | 99.92 CHF |
|---|---|
| Lowest since issue | 91.66 CHF |
| Spread | 8 CHF |
| Spread % | 0.84% |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
128
USD
Average target price
142.7
USD
Spread / Average Target
+11.48%
- Stock Market
- Certificates
- YWSLTQ Certificat
